BBBY — Bed Bath & Beyond Income Statement
0.000.00%
- $451.79m
- $350.03m
- $1.39bn
- 67
- 49
- 93
- 80
Annual income statement for Bed Bath & Beyond, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | C2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,494 | 2,756 | 1,929 | 1,561 | 1,395 |
| Cost of Revenue | |||||
| Gross Profit | 571 | 624 | 508 | 366 | 290 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,397 | 2,645 | 1,902 | 1,705 | 1,589 |
| Operating Profit | 96.7 | 111 | 27 | -144 | -194 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 96.5 | 123 | -33.9 | -266 | -258 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 95.1 | 172 | -35.2 | -308 | -259 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 58.7 | 369 | -35.2 | -308 | -259 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 51.5 | 351 | -36.9 | -308 | -259 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.91 | 3.57 | -0.833 | -6.53 | -5.51 |